Eaton Vance Management Dr Reddys Laboratories LTD Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$48.27 - $65.25 $49,814 - $67,338	-1,032 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$59.5 - $67.25 $3,689 - $4,169	62 Added 6.39%	1,032 $68,000
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $370,529 - $463,485	-6,156 Reduced 86.39%	970 $63,000
Q2 2021 Aug 16, 2021	BUY	$62.12 - $74.2 $374,148 - $446,906	6,023 Added 546.06%	7,126 $523,000
Q1 2021 May 17, 2021	BUY	$57.98 - $73.08 $63,951 - $80,607	1,103 New	1,103 $68,000

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.55B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.